386 filings
Page 2 of 20
8-K
gbl jyy7saa6pg
8 Jan 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:39pm
8-K
50ex7 r6qugza4j69
27 Dec 19
Melinta Therapeutics Announces Restructuring Support Agreement with its Secured Lenders under its Senior Credit Facility
9:03am
8-K
dxio7xbkszmp31kwp
6 Nov 19
Other Events
5:27pm
8-K
4eiqld
24 Oct 19
Other Events
4:05pm
8-K
y9vb4hb
3 Sep 19
Melinta Therapeutics Announces Appointment of Jennifer Sanfilippo to Interim Chief Executive Officer and Director
4:25pm
8-K
u4lklmq0j
9 Aug 19
Melinta Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business Update
7:37am
8-K
el7b57l64ym ed
16 Jul 19
Melinta Therapeutics Announces Preliminary Second Quarter 2019 Financial Results and Provides Corporate Update
4:50pm
8-K
tu8iijjr7u4aygknj0
1 Jul 19
Entry into a Material Definitive Agreement
5:18pm
8-K
yjpd5j29x
11 Jun 19
Submission of Matters to a Vote of Security Holders
12:00am
8-K
dnewwowq
7 Jun 19
Other Events
4:31pm
S-8
pw304xi
16 May 19
Registration of securities for employees
5:30pm
8-K
cucpak20
9 May 19
Melinta Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
4:16pm
8-K
9fumcf 0uykas
13 Mar 19
Melinta Therapeutics Reports Fourth Quarter and Full-Year
4:04pm
8-K
dxwzepcpp1edhduusyuq
25 Feb 19
Entry into a Material Definitive Agreement
8:15am
8-K
dq32c
21 Feb 19
Melinta Therapeutics AnnouncesOne-for-Five Reverse Stock Split
5:22pm